Aqualung Therapeutics Corporation
PrivateLast Round
Grant
Sep 15, 2025
Total Funding Raised
$14.93M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Aqualung Therapeutics Corporation is a biotechnology company that develops an immune-focused biologic platform for serious inflammatory disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aqualung Therapeutics Corporation Comparables
Compare Aqualung Therapeutics Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Implicit Bioscience | 83% | |
| BioAegis Therapeutics | 81% | |
| Vasomune Therapeutics | 81% |
Aqualung Therapeutics Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 15, 2025 | ||||
| Series A Extension | Jul 18, 2023 | ||||
| Series A | Oct 1, 2022 | ||||
| Grant | Sep 21, 2022 | ||||
| Convertible Debt | Jan 18, 2022 | ||||
Grant | Jun 2, 2020 |
Aqualung Therapeutics Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Florida Venture Forum | Series A Extension |
| JSR Life Sciences | Convertible Debt, Series A |
| DeepWork Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 26, 2026
Monthly visitors grew 108% MoM, reaching 1.9K.
- Sep 15, 2025
$1.2M grant received from NIH RADx.
Aqualung Therapeutics Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aqualung Therapeutics Corporation's valuation, stock price, and market status.
Is Aqualung Therapeutics Corporation a public or private company?
Aqualung Therapeutics Corporation is a private company.
What is the current stock price of Aqualung Therapeutics Corporation?
Aqualung Therapeutics Corporation is a private company with no public stock price. No recent secondary market data is available.
How much is Aqualung Therapeutics Corporation worth (valuation)?
Valuation information for Aqualung Therapeutics Corporation is not publicly available.
Can I buy Aqualung Therapeutics Corporation stock?
Aqualung Therapeutics Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aqualung Therapeutics Corporation's last funding round?
Aqualung Therapeutics Corporation's most recent funding round was Grant on September 15, 2025.
Who are the main investors in Aqualung Therapeutics Corporation?
Key investors in Aqualung Therapeutics Corporation include JSR Life Sciences.
Will Aqualung Therapeutics Corporation IPO soon?
No public IPO plans have been announced for Aqualung Therapeutics Corporation.
How can I track Aqualung Therapeutics Corporation secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aqualung Therapeutics Corporation's secondary market activity and sign up for updates.